Skip to main navigation
Telesis Bio Logo
    • Home
    • Products
      • Coronavirus
        • RNA controls
        • Synthetic genomes
        • Services
        • Resources
      • BioXp™ system
        • Gene synthesis
        • DNA cloning
        • Libraries
        • Resources
      • Benchtop reagents
        • Gibson assembly kits
        • RapidAMP kits
        • Vmax X2 cells
        • Resources
      • Services
        • Contact
    • Workflows
      • Research applications
        • Antibody drug discovery
        • Genome editing
        • Metabolic engineering
      • Clinical applications
        • Precision medicine
        • Vaccine development
        • Immune monitoring
        • Regenerative medicine
    • Innovation
      • SOLA Technology
    • About
      • Leadership
      • Careers
      • Press + news
      • Distributors
      • Events
      • Legal
      • Blog
    • Investors
      • News & Events
      • Stock Info
      • Corporate Governance
      • Financials & Filings
      • IR Resources
    • Order
    • Contact
  • Order
  • Support

Investor Relations

  • Investors
  • News + events
    • News Releases
    • Events
    • Presentations
  • Stock information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Corporate governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • Financials + filings
    • SEC Filings
    • Annual Reports & Proxies
    • Quarterly Results
  • IR resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Board of Directors

Corporate Governance menu

Corporate Governance menu

  • Documents + Charters
  • |
  • Board of Directors
  • |
  • Management Team
  • |
  • Committee Composition
Todd R. Nelson, PhD
Todd R. Nelson PhD
Chief Executive Officer
Read More
Read More
William Snider
Member of the Audit Committee
Member of the Compensation Committee
Andrea Jackson
Member of the Compensation Committee
Member of the Nominating and Corporate Governance Committee
Frank Witney
Member of the Audit Committee
Chair of the Compensation Committee
Christine Tsingos
Chair of the Audit Committee
Jami Nachtsheim
Chair of the Nominating and Corporate Governance Committee

About Telesis Bio

Telesis Bio Inc. is building biology. Creators of the BioXp® system, the world’s only fully automated gene synthesis platform, and the industry-standard Gibson Assembly® method, Telesis Bio Inc. is focused on enabling researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA.

Telesis Bio Inc. is accelerating advances in the fields of personalized medicine, biologics drug discovery, vaccine development, genome editing, and cell and gene therapy.

Site

  • Products
  • Workflows
  • Support
  • About
  • Investors
  • Order
  • Contact

Links

  • Events
  • Blog
  • Careers
  • Terms of use
  • Cookie policy
  • Privacy policy
  • Legal

© 2023 Telesis Bio Inc. All rights reserved.

Telesis Bio Logo